Weihong Ding

817 total citations
27 papers, 629 citations indexed

About

Weihong Ding is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Weihong Ding has authored 27 papers receiving a total of 629 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Surgery, 11 papers in Pulmonary and Respiratory Medicine and 11 papers in Oncology. Recurrent topics in Weihong Ding's work include Bladder and Urothelial Cancer Treatments (10 papers), Prostate Cancer Treatment and Research (8 papers) and Urinary and Genital Oncology Studies (6 papers). Weihong Ding is often cited by papers focused on Bladder and Urothelial Cancer Treatments (10 papers), Prostate Cancer Treatment and Research (8 papers) and Urinary and Genital Oncology Studies (6 papers). Weihong Ding collaborates with scholars based in China, Japan and United States. Weihong Ding's co-authors include Ke Xu, Guowei Xia, Chuanyu Sun, Yuancheng Gou, Qiang Ding, Yuan Gao, Shijun Tong, Qingfeng Hu, Shen Gao and Zhongqing Chen and has published in prestigious journals such as PLoS ONE, Biochemical and Biophysical Research Communications and British Journal of Pharmacology.

In The Last Decade

Weihong Ding

26 papers receiving 623 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Weihong Ding China 13 266 211 201 164 146 27 629
Qilin Ao China 12 268 1.0× 124 0.6× 219 1.1× 80 0.5× 161 1.1× 43 689
Chiuan‐Ren Yeh United States 16 340 1.3× 218 1.0× 185 0.9× 107 0.7× 207 1.4× 21 819
Kenji Taketani Japan 14 224 0.8× 226 1.1× 152 0.8× 123 0.8× 100 0.7× 26 534
Sylvia Timme Germany 17 369 1.4× 388 1.8× 133 0.7× 234 1.4× 179 1.2× 37 795
Zhibo Xie China 13 206 0.8× 205 1.0× 60 0.3× 74 0.5× 124 0.8× 24 510
Qingsong Xie China 13 282 1.1× 141 0.7× 95 0.5× 113 0.7× 195 1.3× 19 632
Fumiko Chiwaki Japan 16 465 1.7× 179 0.8× 156 0.8× 84 0.5× 178 1.2× 27 718
Zengli Liu China 16 444 1.7× 210 1.0× 103 0.5× 240 1.5× 253 1.7× 48 739
Leandro M. Colli Brazil 15 264 1.0× 170 0.8× 95 0.5× 144 0.9× 139 1.0× 35 689

Countries citing papers authored by Weihong Ding

Since Specialization
Citations

This map shows the geographic impact of Weihong Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weihong Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weihong Ding more than expected).

Fields of papers citing papers by Weihong Ding

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weihong Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weihong Ding. The network helps show where Weihong Ding may publish in the future.

Co-authorship network of co-authors of Weihong Ding

This figure shows the co-authorship network connecting the top 25 collaborators of Weihong Ding. A scholar is included among the top collaborators of Weihong Ding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weihong Ding. Weihong Ding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Yunxia, Weihong Ding, Wenjing Hao, et al.. (2024). CXCL3/TGF-β-mediated crosstalk between CAFs and tumor cells augments RCC progression and sunitinib resistance. iScience. 27(7). 110224–110224. 7 indexed citations
2.
Huang, Xiting, Qian Wang, Yanyang Nan, et al.. (2024). Targeting CD47 and Angiogenesis Demonstrates Effective Anti-Tumor Effect in Bladder Cancer. Biomedicines. 12(9). 2152–2152.
3.
Wang, Yunxia, Xiaolin Liu, Weihong Ding, et al.. (2023). Mechanisms of sunitinib resistance in renal cell carcinoma and associated opportunities for therapeutics. British Journal of Pharmacology. 180(23). 2937–2955. 14 indexed citations
4.
Ding, Weihong, Zhiyu Qian, Quangang Zhu, et al.. (2021). Immunotherapy Strategy Targeting Programmed Cell Death Ligand 1 and CD73 with Macrophage-Derived Mimetic Nanovesicles to Treat Bladder Cancer. Molecular Pharmaceutics. 18(11). 4015–4028. 37 indexed citations
5.
Jiang, Guangliang, Hui Wang, Da Huang, et al.. (2021). The Clinical Implications and Molecular Mechanism of CX3CL1 Expression in Urothelial Bladder Cancer. Frontiers in Oncology. 11. 752860–752860. 12 indexed citations
6.
Ding, Weihong, Kewei Ren, Jiangang Zou, et al.. (2018). Association between three genetic variants in kallikrein 3 and prostate cancer risk. Bioscience Reports. 38(6). 10 indexed citations
7.
Wang, Hui, Weihong Ding, Guangliang Jiang, et al.. (2018). EORTC risk tables are more suitable for Chinese patients with nonmuscle-invasive bladder cancer than AUA risk stratification. Medicine. 97(36). e12006–e12006. 3 indexed citations
8.
Jiang, Guangliang, Qingfeng Hu, Hui Wang, et al.. (2018). A Cumulative Analysis of Current Evidence for Association between Expression of Epithelial-Mesenchymal Transition Markers and Clinicopathological Outcomes in Patients after Radical Prostatectomy.. PubMed. 48(1). 18–28. 1 indexed citations
9.
10.
Mi, Yuanyuan, Chuanyu Sun, Bingbing Wei, et al.. (2017). Coatomer subunit beta 2 (COPB2), identified by label-free quantitative proteomics, regulates cell proliferation and apoptosis in human prostate carcinoma cells. Biochemical and Biophysical Research Communications. 495(1). 473–480. 18 indexed citations
11.
Mi, Yuanyuan, Menglei Yu, Lifeng Zhang, et al.. (2016). COPB2 Is Upregulated in Prostate Cancer and Regulates PC-3 Cell Proliferation, Cell Cycle, and Apoptosis. Archives of Medical Research. 47(6). 411–418. 29 indexed citations
12.
Hu, Qingfeng, Shijun Tong, Weihong Ding, et al.. (2015). Periostin Mediates TGF-β-Induced Epithelial Mesenchymal Transition in Prostate Cancer Cells. Cellular Physiology and Biochemistry. 36(2). 799–809. 69 indexed citations
13.
Ding, Weihong, Shijun Tong, Yuancheng Gou, et al.. (2015). Human epidermal growth factor receptor 2: a significant indicator for predicting progression in non-muscle-invasive bladder cancer especially in high-risk groups. World Journal of Urology. 33(12). 1951–1957. 23 indexed citations
14.
Gou, Yuancheng, Weihong Ding, Ke Xu, et al.. (2014). Snail is an independent prognostic indicator for predicting recurrence and progression in non-muscle-invasive bladder cancer. International Urology and Nephrology. 47(2). 289–293. 12 indexed citations
15.
Ding, Weihong, Zhongqing Chen, Yuancheng Gou, et al.. (2014). Are EORTC risk tables suitable for Chinese patients with non-muscle-invasive bladder cancer?. Cancer Epidemiology. 38(2). 157–161. 12 indexed citations
16.
Hu, Qingfeng, Yuancheng Gou, Chuanyu Sun, et al.. (2013). The prognostic value of C-reactive protein in renal cell carcinoma: A systematic review and meta-analysis. Urologic Oncology Seminars and Original Investigations. 32(1). 50.e1–50.e8. 68 indexed citations
17.
Ding, Weihong, Yuancheng Gou, Chuanyu Sun, et al.. (2013). Ki-67 is an independent indicator in non–muscle invasive bladder cancer (NMIBC); Combination of EORTC risk scores and Ki-67 expression could improve the risk stratification of NMIBC. Urologic Oncology Seminars and Original Investigations. 32(1). 42.e13–42.e19. 45 indexed citations
18.
Chen, Zhongqing, Weihong Ding, Ke Xu, et al.. (2012). The 1973 WHO Classification Is More Suitable than the 2004 WHO Classification for Predicting Prognosis in Non-Muscle-Invasive Bladder Cancer. PLoS ONE. 7(10). e47199–e47199. 33 indexed citations
19.
Sun, Chuanyu, et al.. (2012). Primitive neuroectodermal tumor of the kidney: case report and review of literature. World Journal of Surgical Oncology. 10(1). 279–279. 7 indexed citations
20.
Sun, Chuanyu, Jian Gong, Weiwei Liu, et al.. (2011). Periostin: a promising target of therapeutical intervention for prostate cancer. Journal of Translational Medicine. 9(1). 99–99. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Qilin Ao Breakdown of academic impact, for papers by Chiuan‐Ren Yeh Breakdown of academic impact, for papers by Kenji Taketani Breakdown of academic impact, for papers by Sylvia Timme Breakdown of academic impact, for papers by Zhibo Xie Breakdown of academic impact, for papers by Qingsong Xie Breakdown of academic impact, for papers by Fumiko Chiwaki Breakdown of academic impact, for papers by Zengli Liu Breakdown of academic impact, for papers by Leandro M. Colli
Rankless by CCL
2026